1. null
   Yutaka Nezu et al, 2017 CrossRef
2. miR-155 Promotes ox-LDL-Induced Autophagy in Human Umbilical Vein Endothelial Cells
   Zhaozhi Zhang et al, 2017, Mediators of Inflammation CrossRef
3. Autophagy activated by the c-Jun N-terminal kinase-mediated pathway protects human prostate cancer PC3 cells from celecoxib-induced apoptosis
   Xin Zhu et al, 2017 CrossRef
4. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.
   Recep Bayraktar et al, 2018, Cancer Metastasis Rev CrossRef
5. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway
   Lin Wang et al, 2018, Cancer Biotherapy and Radiopharmaceuticals CrossRef
6. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis
   Pablo Berlanga et al, 2016 CrossRef
7. The cycloartane triterpenoid ADCX impairs autophagic degradation through Akt overactivation and promotes apoptotic cell death in multidrug-resistant HepG2/ADM cells
   Haiyan Sun et al, 2017, Biochemical Pharmacology CrossRef
8. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma
   Jian-ling Wang et al, 2016, Yonsei Med J CrossRef
9. Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
   Ruiling Chen et al, 2019, J Cell Mol Med CrossRef
10. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clin Transl Oncol CrossRef
11. Drug resistance-related microRNAs in hematological malignancies: Translating basic evidence into therapeutic strategies
    Lingling Xie et al, 2015, Blood Reviews CrossRef
12. MicroRNAs in osteosarcoma
    Jian Zhang et al, 2015, Clinica Chimica Acta CrossRef
13. miR-155 promotes the growth of osteosarcoma in a HBP1-dependent mechanism
    Xiaohui Sun et al, 2015, Mol Cell Biochem CrossRef
14. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma
    Zaijun Lin et al, 2016, J Cancer Res Clin Oncol CrossRef
15. Low profile high value target: The role of OxLDL in cancer
    Albert V. Bitorina et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids CrossRef
16. Combination therapeutics of doxorubicin with Fe3O4@chitosan@phytic acid nanoparticles for multi-responsive drug delivery
    Dandan Xu et al, 2016, RSC Adv. CrossRef
17. Regulation of multidrug resistance by microRNAs in anti-cancer therapy
    Xin An et al, 2017, Acta Pharmaceutica Sinica B CrossRef
18. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma
    Ren Chen et al, 2017 CrossRef
19. Apicomplexan autophagy and modulation of autophagy in parasite-infected host cells
    Perle Latré de Laté et al, 2017, Biomedical Journal CrossRef
20. The extensive role of miR-155 in malignant and non-malignant diseases
    Diana Gulei et al, 2019, Molecular Aspects of Medicine CrossRef
21. Biological analysis of cancer specific microRNAs on function modeling in osteosarcoma
    Hao Wang et al, 2017, Sci Rep CrossRef
22. MiR-155 aggravates impaired autophagy of pancreatic acinar cells through targeting Rictor
    Xueming Zhang et al, 2020 CrossRef
23. Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy
    Zeinab Jamali et al, 2020, IUBMB Life CrossRef
24. Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation
    Sara Pagotto et al, 2018, Oncotarget CrossRef
25. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
    Yu‑Xin Liao et al, 2019, Int J Oncol CrossRef
26. MicroRNA‑155 promotes ox‑LDL‑induced autophagy in human umbilical vein endothelial cells by targeting the PI3K/Akt/mTOR pathway.
    Shuangshuang Yin et al, 0 CrossRef
27. MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
    Milad Ashrafizadeh et al, 2020, European Journal of Pharmacology CrossRef
28. Recent Insights into Therapy Resistance in Osteosarcoma
    Zachary D. Prudowsky et al, 2020, Cancers CrossRef
29. Noncoding RNAs in osteosarcoma: Implications for drug resistance
    Zhengjun Lin et al, 2021, Cancer Letters CrossRef
30. Tannic acid enhances cisplatin effect on cell proliferation and apoptosis of human osteosarcoma cell line (U2OS)
    Mohamad Zahid Kasiram et al, 2021, Pharmacol. Rep CrossRef
31. A genome-wide expression profile of noncoding RNAs in human osteosarcoma cells as they acquire resistance to cisplatin
    Harshita Sharma et al, 2021, Discov Onc CrossRef
32. Roles of the miR-155 in Neuroinflammation and Neurological Disorders: A Potent Biological and Therapeutic Target
    Seyed Hamidreza Rastegar-Moghaddam et al, 2022, Cell Mol Neurobiol CrossRef
33. The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
    Yuhe Lei et al, 2022, Front. Oncol. CrossRef
34. MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity
    Negin Soghli et al, 2022, Biochemical Pharmacology CrossRef
35. null
    Javid Sadri Nahand et al, 2022 CrossRef
36. Non-coding RNAs in drug and radiation resistance of bone and soft-tissue sarcoma: a systematic review
    Huan-Huan Chen et al, 2022 CrossRef
37. miR-155-3p: processing by-product or rising star in immunity and cancer?
    Owen Dawson et al, 2022, Open Biol. CrossRef
38. The Diagnostic and Prognostic Value of miR-155 in Cancers: An Updated Meta-analysis
    Yanan Wu et al, 2023, Mol Diagn Ther CrossRef
39. miRNAs as potential game-changers in bone diseases: Future medicinal and clinical Uses
    Ahmed S. Doghish et al, 2023, Pathology - Research and Practice CrossRef
40. Relationship Between Autophagy and Drug Resistance in Tumors
    Xuan Hu et al, 2023, MRMC CrossRef